| Northeast Ohio Eye Surgeons | |
|
3583 Reserve Commons Dr, Medina, OH 44256-8180 | |
| (330) 722-8300 | |
| (330) 725-0445 |
| Full Name | Northeast Ohio Eye Surgeons |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 3583 Reserve Commons Dr, Medina, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568581965 | NPI | - | NPPES |
| 000000292120 | Other | ANTHEM | |
| 2666164 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Primary |
| 332H00000X | Eyewear Supplier | (* (Not Available)) | Secondary |
| Provider Name | Amy M Fernandez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952352015 PECOS PAC ID: 1759365786 Enrollment ID: I20040616000857 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Provider Name | Thomas Sk Chi |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1851341846 PECOS PAC ID: 1850369612 Enrollment ID: I20050315000197 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Provider Name | Sara M Prusinski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629147566 PECOS PAC ID: 5496785230 Enrollment ID: I20061212000455 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Provider Name | Myron Bodnar |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1457356032 PECOS PAC ID: 0446392765 Enrollment ID: I20100126000206 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Provider Name | Jennifer Sidun Vincent |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1326483546 PECOS PAC ID: 7214166321 Enrollment ID: I20140213001193 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Provider Name | Jenna Ranae Bernard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417696873 PECOS PAC ID: 0648650614 Enrollment ID: I20220707003777 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northeast Ohio Eye Surgeons 3583 Reserve Commons Dr, Medina, OH 44256-8180 Ph: (330) 722-8300 | Northeast Ohio Eye Surgeons 3583 Reserve Commons Dr, Medina, OH 44256-8180 Ph: (330) 722-8300 |
News Archive
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.
The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.
› Verified 1 days ago